Radnet, Inc. · NASDAQ:RDNT
Radnet — Investor Presentation (July 2024)
23 slides from Radnet's investor presentation, Jul 18, 2024
Slide 1: RadNet Investor Presentation July 2024
Mark Stolper Chief Financial Officer ms@radnet.com July 2024 NASDAQ: RDNT
Slide 2: Safe Harbor
Safe Harbor This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning RadNet’s ability to continue to grow the business by generating patient referrals and contracts with radiology practi
Slide 3: Introduction
1 Introduction 2 Diagnostic Imaging Industry Overview 3 Overview of RadNet 4 Financial Information and Core Strategy
Slide 4: RadNet Summary
RadNet Summary Largest national owner and operator of fixed-site diagnostic imaging centers, with 375 locations • Founded as a one center CA operation in 1980 • Established, reputable player in the highly fragmented imaging industry • 36.5% of RadNet centers are held within joint ventures with large
Slide 5: RadNet Summary (continued)
RadNet Summary (continued) Emphasis placed on scale and “multi-modality” strategy • Offering the full breadth of procedures, benefiting our patients and referral sources • Lessens our exposure to reimbursement changes; diversifies revenue base Proven capabilities as an acquiror and integrator improv
Slide 6: Types of Imaging Exams: Modalities
Types of Imaging Exams: Modalities Advanced Imaging MRI CT PET Produces high-resolution cross-sectional images Produces high-resolution cross-sectional images. Determines metabolic activity. Applications: of soft tissue. Applications: Assesses brain, spinal Applications: Assesses tumors, strokes, As
Slide 7: Diagnostic Imaging Industry Overview
1 Introduction 2 Diagnostic Imaging Industry Overview 3 Overview of RadNet 4 Financial Information and Core Strategy
Slide 8: Diagnostic Imaging: A Large and Growing Market
Diagnostic Imaging: A Large and Growing Market Diagnostic Imaging Procedure Volume (1) US Imaging Centers (by State and Region, 2013) 730 695 712 663 678 635 648 608 622 596 2.4% 2.5% 2.5% 2.7% 2.1% 2.1% 2.2% 2.3% 1.8% 1.9% 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Annual Imaging Procedures
Slide 9: Diagnostic Imaging: A Large and Growing Market
Diagnostic Imaging: A Large and Growing Market Growth has resulted from … • Aging population – 65-year-old demographic is expected Shift to Outpatient Services to increase significantly driven by… • Growing population – particularly in California, our largest presence • Payors steering volume to les
Slide 10: Industry Consolidation and Rationalization
Industry Consolidation and Rationalization Independent operators can often face challenges: • Not well capitalized and have a higher cost structure • Not able to make investments in newer technology • Unable to do network contracting or capitate with payors 2020–2023, we spent Higher facility accred
Slide 11: Overview of RadNet
1 Introduction 2 Diagnostic Imaging Industry Overview 3 Overview of RadNet 4 Financial Information and Core Strategy
Slide 12: Scale and Operating Leverage in Targeted Geographies
Scale and Operating Leverage in Targeted Geographies Largest owner-operator of fixed-site imaging centers in the U.S. 375 Imaging Centers RadNet operates in states with ~25% of the U.S. population. NJ: 34 DE: 11 NY: 93 MD: 68 FL: 4 CA: 147 AZ: 18 +10,000 +750 26 Radiologists with Employees Joint Ven
Slide 13: Diversified Revenue Mix Mitigates Reimbursement Risk
Diversified Revenue Mix Mitigates Reimbursement Risk Emphasis placed on multi-modality strategy • “One-stop-shopping” for referral sources • Lessens exposure to reimbursement changes, diversifies revenue base Extensive offering of all routine imaging procedures partially insulates us from reimbursem
Slide 14: Varied Payor Mix Mitigates Reimbursement Risk
Varied Payor Mix Mitigates Reimbursement Risk (continued) Strong payor relationships – RadNet is a critical provider of diagnostic imaging solutions to healthcare insurance providers Payor diversity mitigates exposure to possible unfavorable reimbursement trends within any one payor class Exclusive
Slide 15: Capitated Contracts Highlight RadNet's Unique Capabilities
Capitated Contracts Highlight RadNet’s Unique Capabilities RadNet has over 30 capitated medical groups California with whom we work We receive a per-member-per-month fixed price for exclusively providing outpatient imaging to over 1,900,000 lives in CA (HMO commercial, Medicare Advantage and Managed
Slide 16: RadNet Joint Venture Strategy
RadNet Joint Venture Strategy RadNet has 26 joint ventures with hospital and health system partners • About 1/2 of the ventures are unconsolidated (RadNet’s ownership is between 35%–55%) • Remaining 1/2 of ventures are consolidated (RadNet’s ownership is between 49%–94%) • Notable partners include M
Slide 17: RadNet Digital Health - Informatics
RadNet Digital Health - Informatics In November 2023, RadNet launched DeepHealth OS, a pioneering health informatics portfolio Cloud-native operating system (OS), powered by clinical AI, that improves disease detection and that leverages operational generative AI Includes eRAD Radiology Information
Slide 18: RadNet Digital Health - Artificial Intelligence
RadNet Digital Health - Artificial Intelligence RadNet created an Artificial Intelligence subsidiary to pursue opportunities in cancer screening for large patient populations; focus on the four most prevalent cancers of Breast, Prostate, Lung and Colon Acquired Deep Health in Apr 2020 • Focused on i
Slide 19: Financial Information and Core Strategy
1 Introduction 2 Diagnostic Imaging Industry Overview 3 Overview of RadNet 4 Financial Information and Core Strategy
Slide 20: Strong Q1 Performance
Strong Q1 Performance Revenue Adjusted EBITDA Aggregate Procedures Same-Center Procedures ↑ 10.5% Up from 1Q 2023 ↑ 21.4% ↑ 5.7% ↑ 3.7% Up from 1Q 2023 Up from 1Q 2023 Up from 1Q 2023 • Total Company Adjusted EBITDA margins increased by 120bps from last year’s first quarter • AI Revenue within the D
Slide 21: Increased 2024 Guidance After Strong Start to the Year
Increased 2024 Guidance After Strong Start to the Year Imaging Center Segment Original Revised Guidance Range Guidance Range Total Net Revenue $1,650 - $1,700 million $1,675 - $1,725 million Adjusted EBITDA $250 - $260 million $255 - $265 million Capital Expenditures(a) $125 - $135 million $130 - $1
Slide 22: Proven Track Record of Consistent Revenue, EBITDA and Procedural Volume Growth
Proven Track Record of Consistent Revenue, EBITDA and Procedural Volume Growth Net Revenue Reported Adjusted EBITDA $1,800 $232 $1,617 COVID Impact $1,600 $225 $209 $1,430 $202(1) $1,400 R: 8.8% $1,315 ’23 CA G $205 .8% ‘09– $1,154 R: 5 $1,200 $1,071 CA G $185 ’23 ($ in Millions) ‘09– ($ in Millions
Slide 23: Current Capitalization and Valuation
Current Capitalization and Valuation Valuation Metrics 1 Equity Market Capitalization @ $61.25 per share $ 4,525.2 mm Net Debt - 03/31/24 2 314.6 mm Curent Enterprise Value $ 4,839.8 mm Midpoint of 2024 Revised Total Company EBITDA Guidance $ 274.0 mm Net Leverage (Net Debt/Midpoint 2024 EBITDA Guid